This article is actively undergoing a major edit for a little while. To help avoid edit conflicts, do not edit it while this notice is displayed.This notice was added at 14:42, 5 September 2025 (UTC). This page was last edited 75 seconds ago, at 00:37, 6 September 2025 (UTC) (refresh). Please remove this template if this page hasn't been edited for a significant time. If you added this notice, remember to remove it or replace it with {{under construction}} between editing sessions.
Israeli health-technology company
OneStep
Company type
Private
Industry
Health care; Medical software; Digital health
Founded
2019
Founders
Tomer Shussman; Yuval Naveh; Shahar Davidson; Amir Milo
Headquarters
Area served
United States; Israel (primary markets)
Key people
Tomer Shussman (CEO); Yuval Naveh (CSO); Shahar Davidson (CTO); Amir Milo (Executive Chairman)
OneStep (stylized ONESTEP) is an Israeli health-technology company that develops smartphone-based motion analysis and digital care software for healthcare providers. Its platform transforms a patient’s smartphone into a clinical-grade motion lab for gait and mobility assessment, fall-risk detection, remote therapeutic monitoring, and outcomes tracking across hospitals, clinics, senior living communities, and orthotics/prosthetics services.[1][2][3]
History
OneStep was founded by Tomer Shussman, Yuval Naveh, Shahar Davidson and Amir Milo in Tel Aviv in late 2019.[4][5][2] In February 2020, the company completed early seed financing and began initial market activity.[6] In January 2022, OneStep closed a Series A round of $9 million, and in October 2024, it announced a $36 million Series B led by Team8 and Vintage, bringing the company’s disclosed total funding to about $48 million.[7][2][1][8]
On 8 February 2022, OneStep started a partnership with Kinomatic for pre/post-op physical-therapy programs.[9] In August, the company launched fall-risk detection capability that uses smartphone-collected gait trends to alert clinicians of increased fall risk,[10][11][12] and in November, launched upper-body range-of-motion capabilities.[13][14]
In April 2023, OneStep partnered with FOX Rehabilitation in senior-care deployments and joint programs,[15] which in October 2024, was named a Silver Innovator of the Year by McKnight’s Tech Awards.[16] In June, the company announced a research collaboration with the Icahn School of Medicine at Mount Sinai.[17][18] In December, OneStep was selected in PM360’s 2023 Innovations list (Telehealth/Telemedicine category).[19]
In April 2024, OneStep, together with NovaCare Prosthetics & Orthotics, started a research collaboration on remote physical-therapy validation.[20] In February 2025, OneStep integrated with Yardi to extend mobility and fall-risk monitoring into senior-living management workflows.[21][22]
Activities and products
OneStep’s main product is a smartphone app and clinician portal that extract spatiotemporal gait and motion parameters from a phone carried on the person, requiring no extra wearable sensors. The technology is used for remote therapeutic monitoring (RTM), post-operative rehabilitation, fall-risk management, orthotics/prosthetics fitting and population-level monitoring in senior-living and health-system settings.[23][24][25][26]
Validation studies and peer-reviewed research have examined OneStep’s smartphone-based gait analysis in relation to standard functional measures such as the Timed Up and Go (TUG) and Six-Minute Walk Test (6MWT).[10][27][28]
Reviews
A peer‑reviewed study published in the Journal of Orthopaedic Surgery and Research in 2022 found that the OneStep smartphone app provides “moderate‑to‑excellent” reliability compared with a motion‑capture laboratory and concluded it is a feasible alternative for gait assessment.[10]
In 2024, health-tech news outlets reported that the platform was in use by over 20 providers across multiple care settings and had been integrated with EHR systems such as PointClickCare.[29]
Regulatory status
OneStep’s device, manufactured by Celloscope Ltd. (Tel Aviv – Jaffa, Israel), is listed in the U.S. Food and Drug Administration’s (FDA) Establishment Registration & Device Listing database under product code ISD (“Exerciser, measuring”), which denotes a Class I, 510(k)-exempt device. Celloscope Ltd.’s FDA facility registration (Owner/Operator Number 10084556; Registration Number 3021907566) and its device listing are publicly available.[30]
